# Use of Transexamic Acid in Hip Replacement

> **NCT02587845** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 150 (estimated)

## Conditions studied

- Bleeding
- Transfusion Related Complication

## Interventions

- **DRUG:** Tranexamic Acid (IV)
- **DRUG:** Tranexamic Acid (Topical)

## Key facts

- **NCT ID:** NCT02587845
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2015-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587845, "Use of Transexamic Acid in Hip Replacement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02587845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*